Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Group A
: In Group A, the patients with lymphedema will undergo intensive treatment delivered by the Lymphedema Therapist for first 2 weeks, which will include, Manual lymphatic Drainag
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women older than 18 years of age and clinically diagnosed with unilateral upper limb edema after completion of breast cancer treatment. 2. Lymphoedema that has not been previously treated. 3. ISL stage 2 and above lymphedema. 4. Should be able to read and write English
Exclusion criteria
Exclusion criteria: 1. Bilateral upper limb lymphedema 2. Oedema due to any other cause. 3. Infection in the oedematous upper limb 4. Patients with cognitive impairment 5. Patients with metastases or local recurrence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: â?¢To evaluate the effectiveness of hybrid bandages in limb volume reduction in Lymphedema management Timepoint: Limb volume will be assessed at baseline before intervention, after intensive therapy (2 weeks), 6 weeks and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: â?¢ To assess the acceptance and experience of hybrid bandages by the patients with lymphedema. â?¢ To assess the Quality of life. Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactAnuradha Daptardar
Tata Memorial Hospital
Outcome results
None listed